A novel HBsAg-based model for predicting significant liver fibrosis among Chinese patients with immune-tolerant phase chronic hepatitis B: a multicenter retrospective study

por Zeng, Da-Wu, Huang, Zu-Xiong, Lin, Meng-Xin, Kang, Na-Ling, Lin, Xin, Li, Ya-Nan, Zhu, Yue-Yong, Liu, Yu-Rui
Publicado 2021

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients

por Kang, Na-Ling, Zhang, Jie-Min, Lin, Meng-Xin, Chen, Xu-Dong, Huang, Zu-Xiong, Zhu, Yue-Yong, Liu, Yu-Rui, Zeng, Da-Wu
Publicado 2020

Baseline Prognostic Factors and Statistic Model to Predict Early Virological Response in Telbivudine-Treated Patients With Chronic Hepatitis B

por Zhou, Rui, Zhou, Yuan-Ping, Lin, Chun, Gao, Hai-bing, Huang, Shui-wen, Huang, Zu-xiong, Sun, Fang, Lin, Yong, Zhang, Dong-qing, Lin, Qing-feng, Ao, Wen, Pan, Chen
Publicado 2013

Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores

por Kang, Na-Ling, Ruan, Qing-Fa, Zhang, De-Sheng, Yu, Xue-Ping, Hu, Zhen-Ting, Lin, Zhi-Min, Wu, Lu-Ying, Lin, Meng-Xin, Huang, Zu-Xiong, Jiang, Jia-Ji, Liu, Yu-Rui, Mao, Ri-Cheng, Zeng, Da-Wu
Publicado 2022